229 related articles for article (PubMed ID: 32053003)
1. Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy.
Xu L; Ge X; Sun N; Liu X
Acta Radiol; 2020 Oct; 61(10):1316-1325. PubMed ID: 32053003
[TBL] [Abstract][Full Text] [Related]
2. Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.
Sun NN; Ge XL; Liu XS; Xu LL
Radiol Med; 2020 Feb; 125(2):165-176. PubMed ID: 31605354
[TBL] [Abstract][Full Text] [Related]
3. Whole-tumour histogram analysis of pharmacokinetic parameters from dynamic contrast-enhanced MRI in resectable oesophageal squamous cell carcinoma can predict T-stage and regional lymph node metastasis.
Chen YL; Li R; Chen TW; Ou J; Zhang XM; Chen F; Wu L; Jiang Y; Laws M; Shah K; Joseph B; Hu J
Eur J Radiol; 2019 Mar; 112():112-120. PubMed ID: 30777199
[TBL] [Abstract][Full Text] [Related]
4. Oesophageal squamous cell carcinoma: histogram-derived ADC parameters are not predictive of tumour response to chemoradiotherapy.
Kozumi M; Ota H; Yamamoto T; Umezawa R; Matsushita H; Ishikawa Y; Takahashi N; Matsuura T; Takase K; Jingu K
Eur Radiol; 2018 Oct; 28(10):4296-4305. PubMed ID: 29725833
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.
Shukla-Dave A; Lee NY; Jansen JF; Thaler HT; Stambuk HE; Fury MG; Patel SG; Moreira AL; Sherman E; Karimi S; Wang Y; Kraus D; Shah JP; Pfister DG; Koutcher JA
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1837-44. PubMed ID: 21601373
[TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy.
Sun NN; Liu C; Ge XL; Wang J
Diagn Interv Radiol; 2018 Jul; 24(4):195-202. PubMed ID: 30091709
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced magnetic resonance imaging: A novel approach to assessing treatment in locally advanced esophageal cancer patients.
Gu L; Xie X; Guo Z; Shen W; Qian P; Jiang N; Fan Y
Niger J Clin Pract; 2021 Dec; 24(12):1800-1807. PubMed ID: 34889788
[TBL] [Abstract][Full Text] [Related]
8. Combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging to predict neoadjuvant chemotherapy effect in FIGO stage IB2-IIA2 cervical cancers.
Zhang A; Song J; Ma Z; Chen T
Radiol Med; 2020 Dec; 125(12):1233-1242. PubMed ID: 32424659
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome.
Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
Radiother Oncol; 2013 Apr; 107(1):117-22. PubMed ID: 23333024
[TBL] [Abstract][Full Text] [Related]
10. Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: Value of dynamic contrast-enhanced 3.0 T MRI.
Zheng D; Chen Y; Liu X; Chen Y; Xu L; Ren W; Chen W; Chan Q
J Magn Reson Imaging; 2015 Jun; 41(6):1528-40. PubMed ID: 25136770
[TBL] [Abstract][Full Text] [Related]
11. Textural features based enhanced contrast CT images predicts prognosis to concurrent chemoradiotherapy in stage III esophageal squamous cell cancer.
Xie Y; Wang Q; Cao B; Lv J; Wang Y; Wu L; Dong M; Li T
Cancer Biomark; 2020; 27(3):325-333. PubMed ID: 31903981
[TBL] [Abstract][Full Text] [Related]
12. Predicting tumor responses and patient survival in chemoradiotherapy-treated patients with non-small-cell lung cancer using dynamic contrast-enhanced integrated magnetic resonance-positron-emission tomography.
Huang YS; Chen JL; Chen JY; Lee YF; Huang JY; Kuo SH; Yen RF; Chang YC
Strahlenther Onkol; 2019 Aug; 195(8):707-718. PubMed ID: 30610356
[TBL] [Abstract][Full Text] [Related]
13. DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.
Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
Radiat Oncol; 2020 Apr; 15(1):79. PubMed ID: 32293487
[TBL] [Abstract][Full Text] [Related]
14. Clinical response to chemoradiotherapy in esophageal carcinoma is associated with survival and benefit of consolidation chemotherapy.
Zhao Z; Zhang Y; Wang X; Geng X; Zhu L; Li M
Cancer Med; 2020 Aug; 9(16):5881-5888. PubMed ID: 32627960
[TBL] [Abstract][Full Text] [Related]
15. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance.
Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e485-92. PubMed ID: 22014954
[TBL] [Abstract][Full Text] [Related]
17. Assessment of esophageal carcinoma undergoing concurrent chemoradiotherapy with quantitative dynamic contrast-enhanced magnetic resonance imaging.
Lei J; Han Q; Zhu S; Shi D; Dou S; Su Z; Xu X
Oncol Lett; 2015 Dec; 10(6):3607-3612. PubMed ID: 26788177
[TBL] [Abstract][Full Text] [Related]
18. Could perfusion heterogeneity at dynamic contrast-enhanced MRI be used to predict rectal cancer sensitivity to chemoradiotherapy?
Palmisano A; Esposito A; Rancoita PMV; Di Chiara A; Passoni P; Slim N; Campolongo M; Albarello L; Fiorino C; Rosati R; Del Maschio A; De Cobelli F
Clin Radiol; 2018 Oct; 73(10):911.e1-911.e7. PubMed ID: 30029837
[TBL] [Abstract][Full Text] [Related]
19. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
[TBL] [Abstract][Full Text] [Related]
20. Role of intravoxel incoherent motion MRI in early assessment of the response of esophageal squamous cell carcinoma to chemoradiotherapy: A pilot study.
Zheng H; Ren W; Pan X; Zhang Q; Liu B; Liu S; He J; Zhou Z
J Magn Reson Imaging; 2018 Aug; 48(2):349-358. PubMed ID: 29297204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
